MedTrace Logo

Clinical Utility of Electrical Impedance Spectroscopy

NCT04161742 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2019-11-13

No results posted yet for this study

Summary

The purpose of this clinical study is to evaluate the clinical utility of the Nevisense in normal clinical practice, i.e. the potential effect of implementing Nevisense in clinical decision making (Human vs Human \& Machine) based on Nevisense measurement at time of biopsy decision.

Conditions

  • Focus of Study: Patients With Suspicion of Melanoma

Interventions

DEVICE

Nevisense

Nevisense measures electrical impedance of skin lesions and provides an output called the electrical impedance spectroscopy (EIS) score

Sponsors & Collaborators

  • SciBase AB

    lead OTHER

Principal Investigators

  • Laura Ferris, MD · University of Pittsburgh

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-31
Primary Completion
2020-06-30
Completion
2020-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04161742 on ClinicalTrials.gov